Pentasa 2 gm Granules (Mesalazine 2gm)

About Pentasa 2gm Prolonged Release Granules 1’s

Pentasa 2gm Prolonged Release Granules 1’s belongs to a class of drugs called ‘anti-inflammatory drugs‘ used to treat ulcerative colitis and Crohn’s disease.  Ulcerative colitis is a type of chronic inflammatory bowel disease that causes inflammation of the large intestine lining (colon). It produces ulcers on the colon’s lining, which may cause bleeding and discharge of pus and mucus.

Pentasa 2gm Prolonged Release Granules 1’s contains Mesalazine, works by inhibiting the production of certain chemical substances such as prostaglandins that cause pain and swelling. Thereby, it reduces inflammation (swelling) in the intestines and provides relief from symptoms such as stomach pain or bleeding.

Take Pentasa 2gm Prolonged Release Granules 1’s as prescribed by your doctor. You recommend using Pentasa 2gm Prolonged Release Granules 1’s for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience diarrhoea, stomach pain, headache, nausea, vomiting or flatulence (gas). Most of these side effects of Pentasa 2gm Prolonged Release Granules 1’s do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Pentasa 2gm Prolonged Release Granules 1’s or any other medicines, please tell your doctor. Pentasa 2gm Prolonged Release Granules 1’s (tablet/suppository) is not recommended for children below 2 years, and Pentasa 2gm Prolonged Release Granules 1’s granules are not recommended for children below 6 years. Please inform your doctor before taking Pentasa 2gm Prolonged Release Granules 1’s if you are pregnant or breastfeeding. Pentasa 2gm Prolonged Release Granules 1’s should be used with caution in the elderly. Avoid taking Pentasa 2gm Prolonged Release Granules 1’s if you have severe kidney failure. If you have stomach pain or cramps, severe headache, fever or rash, stop taking Pentasa 2gm Prolonged Release Granules 1’s and consult a doctor.

Uses of Pentasa 2gm Prolonged Release Granules 1’s

Ulcerative colitis, Crohn’s disease

Medicinal Benefits

Pentasa 2gm Prolonged Release Granules 1’s contains Mesalazine, an anti-inflammatory drugs used in the treatment of ulcerative colitis and Crohn’s disease. It works by inhibiting the production of certain chemical substances such as prostaglandins that cause pain and swelling. Thereby, helps in reducing inflammation (redness and swelling) in the intestines and provides relief from symptoms such as stomach pain or bleeding. Also, Pentasa 2gm Prolonged Release Granules 1’s may prevent further episodes of ulcerative colitis.

Related Product

Directions for Use

Take Pentasa 2gm Prolonged Release Granules 1’s with food to avoid stomach upset. Tablet: The tablet form of Pentasa 2gm Prolonged Release Granules 1’s can be swallowed as a swallow whole with a water glass. Do not crush, chew or break it. Granule: The granules form of Pentasa 2gm Prolonged Release Granules 1’s can be taken by directly placing the pack contents on the tongue and drinking some water or orange juice. They can also be mixed with yoghurt and should be taken immediately without chewing on granules. Suppository: The suppository form of Pentasa 2gm Prolonged Release Granules 1’s should be inserted into the rectum (back passage) by removing the plastic wrapper. Wash your hands before and after inserting the suppository.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Pentasa 2gm Prolonged Release Granules 1’s

• Diarrhoea
• Stomach pain
• Headache
• Nausea
• Vomiting
• Flatulence (gas)

In-Depth Precautions and Warning

Drug Warnings

If you are allergic to Pentasa 2gm Prolonged Release Granules 1’s or any other medicines, please tell your doctor. Pentasa 2gm Prolonged Release Granules 1’s (tablet/suppository) is not recommended for children below 2 years, and Pentasa 2gm Prolonged Release Granules 1’s granules are not recommended for children below 6 years. Please inform your doctor before taking Pentasa 2gm Prolonged Release Granules 1’s if you are pregnant or breastfeeding. Pentasa 2gm Prolonged Release Granules 1’s should be used with caution in the elderly. Avoid taking Pentasa 2gm Prolonged Release Granules 1’s if you have severe kidney failure. Severe skin reactions such as toxic epidermal necrolysis (skin peeling and blistering) or Stevens-Johnson syndrome (a painful rash that spreads and blisters) can occur in some patients taking Pentasa 2gm Prolonged Release Granules 1’s. Therefore, if you notice any skin reactions while taking Pentasa 2gm Prolonged Release Granules 1’s, please consult a doctor immediately. If you have stomach pain or cramps, severe headache, fever or rash, stop taking Pentasa 2gm Prolonged Release Granules 1’s and consult a doctor. If you have a stomach ulcer, asthma, any medical condition that can cause bleeding, liver, kidney or blood problems, inform your doctor before taking Pentasa 2gm Prolonged Release Granules 1’s.

Drug Interactions

Drug-Drug Interaction: Pentasa 2gm Prolonged Release Granules 1’s may have interaction with a laxative (lactulose), painkillers (aspirin, ibuprofen), immunosuppressants (azathioprine), chemotherapy drugs (thioguanine, mercaptopurine).

Drug- Food Interaction: No interactions found.

Drug-Disease Interaction: If you have a stomach ulcer, a blockage in the stomach, asthma, any medical condition that can cause bleeding, liver, kidney or blood problems, inform your doctor before taking Pentasa 2gm Prolonged Release Granules 1’s.